# A Study of NTRX-07 in Participants With Alzheimer's Disease

> **NCT07058688** · PHASE2 · RECRUITING · sponsor: **NeuroTherapia, Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment

## Interventions

- **DRUG:** NTRX-07
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07058688
- **Lead sponsor:** NeuroTherapia, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-07-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07058688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07058688, "A Study of NTRX-07 in Participants With Alzheimer's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07058688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*